MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tenax Therapeutics (TENX) Earnings Date & Reports

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension... Show more

A.I. Advisor
published Earnings

TENX is expected to report earnings to rise 22.48% to -37 cents per share on April 01

Tenax Therapeutics TENX Stock Earnings Reports
Q4'26
Est.
$-0.38
Q3'26
Beat
by $0.04
Q2'26
Beat
by $0.03
Q1'26
Missed
by $0.12
Q4'25
Missed
by $0.15
The last earnings report on November 05 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 1.52M shares outstanding, the current market capitalization sits at 63.25M.